Ophthalmology · Evidence depth: moderate
Retina (Vitreoretinal Surgery)
Ownership-sensitivity model
The 10 vectors of a physician career.
Every path is scored 0-100 across 10 critical dimensions using public-data signals, modeled assumptions, and verification prompts. Modeled estimate. Not a salary survey. See methodology.
92/100
Income ceiling
Income ceiling
One of the absolute highest ceilings in all of medicine.
The reality
Driven by a massive volume of expensive intravitreal injections (Lucentis, Eylea) for macular degeneration.
The signal
The margin on drugs (the 'buy-and-bill' model) can generate staggering revenue.
The catch
Coupled with ASC ownership for vitrectomies, the financial leverage is immense.
The verdict
An incredible wealth-builder lane for the highly efficient operator.
60/100
Lifestyle control
Lifestyle control
Significantly lower control than general ophthalmology.
The reality
Retinal detachments are urgent, sight-threatening emergencies that do not respect the clock.
The signal
You will frequently be adding complex, 2-hour surgical cases to the end of an already exhausting day.
The catch
The clinic volume for injections is staggering (often 60+ patients a day).
The verdict
A highly profitable, but definitively grueling grind compared to cataracts.
Premium analysis
8 more dimensions scored, with the reasoning behind each
The scores are below. Premium adds what sits behind each one: the claim, the signal supporting it, the limitation that weakens it, and what it should change about your decision.
- Sleep / call burdenLower is better40/100
- Ownership / facility upsideHigher is better85/100
- Geography flexibilityHigher is better70/100
- Innovation / industry adjacencyHigher is better70/100
- Training opportunity costLower is better50/100
- Job-market densityHigher is better65/100
- Malpractice / litigation pressureLower is better55/100
- Burnout-mismatch riskLower is better45/100
Scores are modeled from the specialty module's evidence and are estimates, not measurements. Confidence and data depth are labeled inside every premium card.
DoctorCalculator modeled income structure
Derived model. DirectionalModeled base range
$505k - $640k
Ophtho's top lane: injection volume plus surgical retina.
Production upside
$685k - $860k
High drug-inventory overhead, exceptional volume density; injection clinics run on throughput.
Ownership upside
Very high
Injection-clinic economics (buy-and-bill margins), ASC equity for surgical retina, imaging ancillaries.
Salary-only gap
High
A salaried retina specialist forgoes buy-and-bill drug margin at scale. The field's dominant economics.
Modeled estimate. Not a salary survey. Derived model. Directional only. Verify against real offers, contracts, and local mentors. Income scales with payer mix, ownership, and geography. See methodology.
Want the code-level view behind numbers like these? Open the RVU calculator for this specialty's procedures, CMS times, and locality-adjusted Medicare rates.
External benchmark reference
Verify independently~$550k
External benchmark reference - verify independently. Not ingested DoctorCalculator source data.
Best fit
- The Procedure-Heavy Wealth Builder. Top-tier income through volume, procedures, production, and ownership.
- The Owner-Operator Physician. Not just a job. A business, with facility and equity upside.
Poor fit
- The Lifestyle-First Clinician. A good life on sane hours, and the math actually works.
This path is described at validated confidence (Evidence depth: moderate). Detailed evidence cards are added as the module is validated; we will not manufacture precision before then.